Financial Partners Group (Tennessee)’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$4.11M Buy
47,166
+3,152
+7% +$267K 1.49% 24
2025
Q1
$3.96M Sell
44,014
-283
-0.6% -$25.3K 1.72% 20
2024
Q4
$3.54M Sell
44,297
-230
-0.5% -$19.9K 1.47% 20
2024
Q3
$4.01M Buy
44,527
+1,205
+3% +$101K 1.5% 21
2024
Q2
$3.41M Hold
43,322
1.32% 24
2024
Q1
$3.78M Buy
43,322
+69
+0.2% +$5.89K 1.46% 23
2023
Q4
$3.56M Sell
43,253
-29,234
-40% -$2.23M 1.61% 20
2023
Q3
$5.68M Buy
72,487
+36,073
+99% +$3.02M 2.73% 14
2023
Q2
$3.21M Hold
36,414
1.62% 21
2023
Q1
$2.94M Buy
36,414
+205
+0.6% +$16.7K 1.54% 23
2022
Q4
$2.81M Buy
+36,209
New +$2.93M 1.66% 20

Other funds holding MDT

Financial Partners Group (Tennessee)'s MDT Position: Q2 2025 in Review

Financial Partners Group (Tennessee) increased its Medtronic (MDT) stake by 7.2% in Q2 2025, buying an estimated $267K and bringing the position to 47,166 shares worth $4.11M. The position accounts for 1.49% of the portfolio, ranked #24.

Financial Partners Group (Tennessee) first reported a position in MDT in Q4 2022 and has held it in 11 quarters since. The position peaked at $5.68M in Q3 2023. 2,140 funds tracked by Wall St. Rank hold MDT as of Q2 2025.

  • Financial Partners Group (Tennessee) held 47,166 shares of Medtronic worth $4.11M as of Q2 2025.
  • Financial Partners Group (Tennessee) bought 3,152 Medtronic shares in Q2 2025, an estimated $267K.
  • Medtronic made up 1.49% of Financial Partners Group (Tennessee)'s portfolio in Q2 2025, its #24 holding.
  • Financial Partners Group (Tennessee) first reported a position in Medtronic in Q4 2022 and has held it in 11 quarters since.
  • Financial Partners Group (Tennessee)'s Medtronic position peaked at $5.68M in Q3 2023.
  • 2,140 funds tracked by Wall St. Rank held Medtronic as of Q2 2025.

Based on Financial Partners Group (Tennessee)'s 13F filing for Q2 2025, filed 17 Jul 2025.